Return to Statistics Toolbox

OPLS-DA analysis for Study ST003920

(Analysis AN006436 )

Select one or more experimental factors for Groups 1 and 2. The members of each group should be DIFFERENT.
Group1Experimental factorGroup2
Sample source:293 cells | Sample type:293 cells | Genotype:Control | Treatment:10 uM D9-TML
Sample source:293 cells | Sample type:293 cells | Genotype:Overexpression | Treatment:10 uM D9-TML
Sample source:293 Mito | Sample type:293 Mito | Genotype:KO | Treatment:10 uM D9-TML
Sample source:293 Mito | Sample type:293 Mito | Genotype:Rescue | Treatment:10 uM D9-TML
Sample source:Ecoli | Sample type:Ecoli | Genotype:Control | Treatment:10 uM D9-TML
Sample source:Ecoli | Sample type:Ecoli | Genotype:Overexpression | Treatment:10 uM D9-TML
Sample source:Hepatocytes | Sample type:Hepatocytes | Genotype:Control | Treatment:10 uM D9-TML
Sample source:Hepatocytes | Sample type:Hepatocytes | Genotype:KO | Treatment:10 uM D9-TML
Sample source:Ing Mito | Sample type:Ing Mito | Genotype:Cre | Treatment:10 uM D9-TML
Sample source:Ing Mito | Sample type:Ing Mito | Genotype:Ctl | Treatment:10 uM D9-TML
Sample source:Serum | Sample type:Serum | Genotype:Control | Treatment:72h 6C
Sample source:Serum | Sample type:Serum | Genotype:Control | Treatment:None
Sample source:Serum | Sample type:Serum | Genotype:KO | Treatment:72h 6C
Sample source:Serum | Sample type:Serum | Genotype:KO | Treatment:None
Sample source:Serum | Sample type:Serum | Genotype:Slc25a45AlbKO | Treatment:72h 6C

  logo